Benchmarking of Four Near Infrared Spectroscopy Devices for Long Time Use in Neonates

Schneider, Anna-Maria; Hofstätter, Edda; Brandner, Johannes; Moder, Angelika; Häusler, Silke; Wald, Martin

doi:10.1055/s-0044-102256

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The INVOS device calculates rScO 2 according to the ratio of oxyhemoglobin to total hemoglobin ( 47 , 50 ). In the FORE-SIGHT device, cerebral mixed arterial-venous oxygen saturation is measured by the different absorption of oxygenated and deoxygenated hemoglobin to near-infrared light, thus detecting rScO 2 by the formula rScO 2 = 0.3 SaO 2 + 0.7 ScvO 2 or rScO 2 = 0.3SaO 2 + 0.7 SjvO 2 according to a 30% arterial to 70% venous ratio ( 45 , 51 , 52 ). The effectiveness of monitoring cerebral oxygen saturation varies from device to device.…”

Section: Discussionmentioning

confidence: 99%

Comparing near-infrared spectroscopy—measured cerebral oxygen saturation and corresponding venous oxygen saturations in children with congenital heart disease: a systematic review and meta-analysis

Ma¹,

Zhao²,

Wei³

et al. 2022

Transl Pediatr

View full text Add to dashboard Cite

Background: Near-infrared spectroscopy (NIRS) is a non-invasive approach that measures cerebral regional oxygen saturation (rScO 2 ). In this study, we evaluated the evidence on the validity of NIRS and the interchangeability between NIRS and common invasive approaches by exploring the correlation and consistency and comparing the mean and standard deviation between the NIRS rScO 2 and jugular bulb venous oxygen saturation (SjvO 2 ) as well as central venous oxygen saturation (ScvO 2 ) in the perioperative period of children with congenital heart disease (CHD).Methods: We searched electronic bibliographic databases (PubMed, The Cochrane Library and Embase) and screened the studies that met the inclusion criteria. We included cross-sectional studies of CHD pediatric patients in the perioperative period receiving both tests for NIRS rScO 2 and SjvO 2 or NIRS rScO 2 and ScvO 2 . Methodological quality assessment and heterogeneity analyses were performed. We qualitatively summarized the results of Bland-Altman's analysis. Meta-regression, subgroup analyses, and sensitivity analyses were carried out to explore the causes of heterogeneity.Results: There was no significant difference in Cohen's d between rScO 2 and ScvO 2 or between rScO 2 and SjvO 2 (Cohen's d =0.06, 95% CI: −0.16 to 0.28; Cohen's d =0.03, 95% CI: −0.25 to 0.31, respectively) and notable heterogeneity existed (I 2 =76.0%, P<0.001; I 2 =73.6%, P<0.001, respectively). A positive linear correlation was present between rScO 2 and ScvO 2 or between rScO 2 and SjvO 2 (r=0.58, 95% CI: 0.54 to 0.63; r=0.60, 95% CI: 0.54 to 0.66, respectively) and the heterogeneity was not significant (I 2 =36.7%, P=0.065; I 2 =12.7%, P=0.328, respectively). In most studies, the 95% limits of agreements of Bland-Altman's analysis were large. No evidence of publication bias was observed. Conclusions:The rScO 2 measured by NIRS reflected the SjvO 2 and ScvO 2 monitored by invasive measurements in the perioperative period of children with CHD to some extent. However, wide limits of agreements between rScO 2 and SjvO 2 as well as ScvO 2 indicated that NIRS and SjvO 2 as well as ScvO 2 are not interchangeable. Whether NIRS plays a prominent role in monitoring cerebral oxygen saturation in children with CHD needs further research.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparing near-infrared spectroscopy—measured cerebral oxygen saturation and corresponding venous oxygen saturations in children with congenital heart disease: a systematic review and meta-analysis

Ma¹,

Zhao²,

Wei³

et al. 2022

Transl Pediatr

View full text Add to dashboard Cite

show abstract

Anatomical and physiological variables influencing measurement of regional cerebral oxygen saturation by near infrared spectroscopy using the Sensmart Model X-100TM

Tanaka

Suzuki

Yoshitani

et al. 2020

J Clin Monit Comput

View full text Add to dashboard Cite

Diagnostic and prognostic values of cerebral oxygen saturations measured by INVOS™ in patients with ischemic and hemorrhagic cerebrovascular disease

Eroğlu

Aksel

Yönak

et al. 2019

Turkish Journal of Emergency Medicine

View full text Add to dashboard Cite

Objectives In this study it was aimed to investigate whether measurement of potential changes of cerebral oxygenation saturations due to ischemic or hemorrhagic cerebrovascular diseases have an early diagnostic and prognostic value. Methods Adult patients (≥18 years old) having acute ischemic or hemorrhagic stroke were included in the study. Patients under 18-year-old, those with incomplete data or suspicious diagnosis were excluded. The cerebral oxygen saturations of the patients were compared with the healthy subjects. Patients were also grouped according to their clinical outcomes; good clinical status (group 1) and poor clinical status (group 2). These groups were compared according to the patients’ cerebral oxygen saturations. Results The mean oxygen saturation of the patients and healthy people were similar (59.48% ± 10.6 versus 58.44% ± 9.6). There was no difference between patients and healthy population according to cerebral oxygen saturations. Furthermore, mean oxygen levels were also similar between the hemisphere without lesion and with lesion in the patients group (59.8% ± 11.8 versus 59.2% ± 10.4). When the patients were grouped according to their clinical status, there were 30 patients in group 1 and 15 in group 2. The cerebral oxygen saturations of the hemisphere with lesion were similar between these groups and no statistical difference was observed (59.2% ± 9.3 versus 59.1% ± 12.6, p = 0.9). There was also no statistical difference between the groups when delta oxygen levels of the affected and unaffected hemispheres of the groups were calculated (0.9% ± 6.1 versus 0.13% ± 8.4, p = 0.7). Conclusion Results of this study revealed that there was no difference in cerebral oxygen saturations measured by near-infrared cerebral oximetry system between the patients with cerebrovascular disease and healthy population. Furthermore, our results did not support that the cerebral oxygen saturations may be used for determining the prognosis of the patients with cerebrovascular disease.

show abstract

Benchmarking of Four Near Infrared Spectroscopy Devices for Long Time Use in Neonates

Cited by 3 publications

References 12 publications

Comparing near-infrared spectroscopy—measured cerebral oxygen saturation and corresponding venous oxygen saturations in children with congenital heart disease: a systematic review and meta-analysis

Comparing near-infrared spectroscopy—measured cerebral oxygen saturation and corresponding venous oxygen saturations in children with congenital heart disease: a systematic review and meta-analysis

Anatomical and physiological variables influencing measurement of regional cerebral oxygen saturation by near infrared spectroscopy using the Sensmart Model X-100TM

Diagnostic and prognostic values of cerebral oxygen saturations measured by INVOS™ in patients with ischemic and hemorrhagic cerebrovascular disease

Contact Info

Product

Resources

About